Examples of using Fixed dose in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Each inhalation provides a fixed dose of the medicine.
This fixed combination product should only be used in dogs which require bothactive substances to be administered concomitantly at this fixed dose.
Each tablet contains a fixed dose of dapagliflozin and metformin see section 2.
Since there exists no relation between the final effective dose andthe body weight, a fixed dose per kg body weight is not feasible.
Patients then received fixed doses of 75 or 150 mg/ day in one study and 75 or 225 mg/ day in the other study.
FORTEKOR PLUS is a fixed combination product which should only be used in dogs which require bothactive substances to be administered concomitantly at this fixed dose.
B REYATAZ/RTV with tenofovir/emtricitabine fixed dose 300 mg/200 mg tablets once daily.
Higher fixed doses of PEGASYS plus COPEGUS in patients with certain'difficult-to-treat' characteristics may lead to a better chance of cure.
This is an open-label study of alipogene tiparvovec at a fixed dose of 1x1012 gc/ kg body weight administered by a single series of intramuscular injections.
The fixed doses of Xeplion in these studies were given on days 1, 8, and 36 in the 9-week study, and additionally on day 64 of the 13-week studies.
Their main advantage lies in the fact that fixed doses can be given, without regular laboratory monitoring except in special cases.
Children and patients with poor kidney or liver function who may require dose correction should not take tablets of Combivir as they contain fixed doses of amivudine or zidovudine.
Patients in the first study received a median dose of 0.16 mg/ kg/ day of TRISENOX(range 0.06 to 0.20 mg/ kg/ day)and patients in the multicentre study received a fixed dose of 0.15 mg/ kg/ day.
It is usually used style frond-load as a fixed dose of its effects felt only after a few weeks, and style taking frond-load can be achieved appreciable effects a little earlier.
The efficacy of duloxetine as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week,double-blind, placebo-controlled, fixed dose studies in adults(22 to 88 years) 44 having diabetic neuropathic pain for at least 6 months.
If strategies using higher fixed doses of peginterferon alfa-2a and ribavirin are validated in larger studies, these findings give us hope that more patients living with chronic hepatitis C can be cured.
In both studies, patients were randomised to receive a single intravenous administration of either the recommended tiered dose of approximately 6 mg/kg(see Table 1,section 4.2), a fixed dose of 130 mg ustekinumab, or placebo at week 0.
The efficacy of fixed doses of ulipristal acetate 5 mg and 10 mg once daily was evaluated in two Phase 3 randomised, double-blind, 13 week studies recruiting patients with very heavy menstrual bleeding associated with uterine fibroids.
Diabetic Peripheral Neuropathic Pain: The efficacy of duloxetine as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week, double-blind,placebo-controlled, fixed dose studies in adults(22 to 88 years) having diabetic neuropathic pain for at least 6 months.
From the data provided the CHMP noted that in the fixed dose studies there was a flat dose response curve, providing no suggestion of advantage in terms of efficacy for using higher than the recommended doses. .
In fixed dose studies in a broad population of men with erectile dysfunction, 68%(5 mg), 76%(10 mg) and 80%(20 mg) of patients experienced successful penetrations(SEP 2) compared to 49% on placebo over a three month study period.
Iii The results of a newstudy show that intensifying treatment with a higher fixed dose of PEGASYS along with a higher dose of COPEGUS could yield significantly higher response rates in these difficult-to-cure patients.
In the fixed dose group of 2.5 micrograms per inhalation chest pain, or chest discomfort(32.5%), pharyngolaryngeal pain, or throat irritation(22.5%) and nausea(7.5%)-(all non-serious and mild in intensity)- occurred more frequently in comparison with the adverse events obtained from the placebo controlled phase II and III studies in patients with doses of 2.5 micrograms or 5 micrograms per inhalation.
Patients received 48 weeks of treatment with PEGASYS at either the standard fixed dose of 180 microg/week or a higher fixed dose of 270 microg/week, plus COPEGUS at the standard dose of 1200 mg/day or a higher dose of 1600 mg/day, as follows.
The efficacy of repeated treatment courses fixed doses of ulipristal acetate 5 mg or 10 mg once daily was evaluated in two Phase 3 studies assessing up to 4 intermittent 3-month treatment courses in patients with heavy menstrual bleeding associated with uterine fibroids.
In an 8- week, placebo-controlled trial involving four fixed doses of risperidone(2, 6, 10, and 16 mg/ day, administered twice daily), all four risperidone groups were superior to placebo on the Positive and Negative Syndrome Scale(PANSS) total score.
Response rates after addition of perampanel at fixed doses were less when patients received concomitant CYP3A enzyme-inducing anti-epileptic medicinal products(carbamazepine, phenytoin, oxcarbazepine) as compared to response rates in patient who received concomitant non-enzyme- inducing anti-epileptic medicinal products.
The mean exposure(AUC) during the dosing interval is predicted to be 25% to 70% higher than thatobserved in adults receiving 180 mcg fixed dosing.